Recent advance in the pharmacology of dihydropyrimidinone
- PMID: 22303940
- DOI: 10.2174/138955712799829267
Recent advance in the pharmacology of dihydropyrimidinone
Abstract
Dihydropyrimidinones (DHPMs) are a series of highly valuable small molecules possessing versatile pharmaceutical properties. Although the first one-pot synthesis of DHPMs had been reported more than 100 years ago, the fascinating achievement in DHPMs-based pharmacology during the past century promoted durative interests to the pharmacological and related studies of the scaffold, which lead to the discovery of many new biological functions of DHPMs. Recent pharmacological development on DHPMs-based molecules have been summarized in this review.
Similar articles
-
Highly regioselective synthesis of N-3 organophosphorous derivatives of 3,4-dihydropyrimidin-2(1H)-ones and their calcium channel binding studies.Eur J Med Chem. 2012 Aug;54:397-402. doi: 10.1016/j.ejmech.2012.05.017. Epub 2012 May 26. Eur J Med Chem. 2012. PMID: 22703843
-
Biologically active dihydropyrimidones of the Biginelli-type--a literature survey.Eur J Med Chem. 2000 Dec;35(12):1043-52. doi: 10.1016/s0223-5234(00)01189-2. Eur J Med Chem. 2000. PMID: 11248403 Review.
-
The discovery and optimization of pyrimidinone-containing MCH R1 antagonists.Bioorg Med Chem Lett. 2006 Sep 15;16(18):4723-7. doi: 10.1016/j.bmcl.2006.07.008. Epub 2006 Jul 25. Bioorg Med Chem Lett. 2006. PMID: 16870432
-
Synthesis of new N3-substituted dihydropyrimidine derivatives as L-/T- type calcium channel blockers.Eur J Med Chem. 2017 Jul 7;134:52-61. doi: 10.1016/j.ejmech.2017.03.080. Epub 2017 Apr 3. Eur J Med Chem. 2017. PMID: 28399450
-
Genesis of dihydropyrimidinone(psi) calcium channel blockers: recent progress in structure-activity relationships and other effects.Mini Rev Med Chem. 2009 Jan;9(1):95-106. doi: 10.2174/138955709787001686. Mini Rev Med Chem. 2009. PMID: 19149663 Review.
Cited by
-
Synthesis of new 1,4-dihydropyridine derivative, anti-cancer, bacterial activity, molecular docking and adsorption, distribution, metabolism and excretion analysis.Future Med Chem. 2024;16(22):2371-2382. doi: 10.1080/17568919.2024.2403960. Epub 2024 Oct 23. Future Med Chem. 2024. PMID: 39440485
-
Current progress in asymmetric Biginelli reaction: an update.Mol Divers. 2018 Aug;22(3):751-767. doi: 10.1007/s11030-018-9841-4. Epub 2018 Jun 23. Mol Divers. 2018. PMID: 29936682 Review.
-
Specific TLR4 Blocking Effect of a Novel 3,4-Dihydropyrimidinone Derivative.Front Pharmacol. 2021 Feb 1;11:624059. doi: 10.3389/fphar.2020.624059. eCollection 2020. Front Pharmacol. 2021. PMID: 33597886 Free PMC article.
-
A Five-Component Biginelli-Diels-Alder Cascade Reaction.Front Chem. 2018 Aug 24;6:376. doi: 10.3389/fchem.2018.00376. eCollection 2018. Front Chem. 2018. PMID: 30211156 Free PMC article.
-
Secondary amine-initiated three-component synthesis of 3,4-dihydropyrimidinones and thiones involving alkynes, aldehydes and thiourea/urea.Beilstein J Org Chem. 2014 Jan 29;10:287-92. doi: 10.3762/bjoc.10.25. eCollection 2014. Beilstein J Org Chem. 2014. PMID: 24605149 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous